SR One
Venture Capital
SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested...Founded in 1985
Homepage: http://www.srone.com/
HQ
02142 One BroadwayCambridge
USA MA
Phone: 610.567.1000
SR One at CrunchBase
Russell Greig President, SR One
Carol Ashe Partner
May, 2013
SR One invested $45M in Effector Therapeutics as a Series A round
January, 2013
SR One invested $12M in Aileron Therapeutic as a Series D round
December, 2012
SR One invested $17M in River Vision Development as a Series A round
SR One invested $5.9M in Bicycle Therapeutics as unattributed round
November, 2012
SR One invested $37.5M in Applied Genetics Technologies Corporation as a Series B round
October, 2012
SR One invested $12.5M in Principia BioPharma as a Series A round
SR One invested $35M in Thrasos as a Series C round
SR One invested $30M in Genocea Biosciences as a Series C round
September, 2012
SR One invested $28M in IlluminOss Medical as a Series C round
June, 2012
SR One invested $18M in Auxogyn as a Series B round
January, 2012
SR One invested $20.7M in RaNA Therapeutics as a Series A round
August, 2011
SR One invested $10M in MISSION Therapeutics as unattributed round
June, 2011
SR One invested $24M in Nimbus Discovery as a Series A round
SR One invested $500K in HTG Molecular Diagnostics as a Series D round
SR One invested $15M in Constellation Pharmaceuticals as a Series B round
May, 2011
SR One invested $15M in Springleaf Therapeutics as a Series B round
April, 2011
SR One invested $20.3M in f-star Biotech as unattributed round
January, 2011
SR One invested $35M in Genocea Biosciences as a Series B round
December, 2010
SR One invested $18M in Semprus BioSciences as a Series B round
November, 2010
SR One invested $29M in Syntaxin as a Series C round
October, 2010
SR One invested $4M in Dicerna Pharmaceuticals as a Series B round
September, 2010
SR One invested $28M in iPierian as a Series B round
June, 2010
SR One invested $4.8M in Constellation Pharmaceuticals as a Series B round
May, 2010
SR One invested $43M in NeuroTherapeutics Pharma as a Series B round
December, 2009
SR One invested $12M in CalciMedica as a Series C round
November, 2009
SR One invested $7.5M in Trinity Biosystems as unattributed round
June, 2009
SR One invested $40M in Aileron Therapeutic as a Series D round
SR One invested $13M in Anaphore as a Series A round
January, 2009
SR One invested $25M in Rib-X Pharmaceuticals as unattributed round
SR One invested $4M in CalciMedica as a Series C round
January, 2008
SR One invested $25M in POINT Biomedical as a Series E round
October, 2007
SR One invested $32M in Syntaxin as a Series B round
July, 2007
SR One invested $1.5M in CalciMedica as a Series A round
May, 2006
SR One invested $12.7M in Onyvax as a Series C round
1985
SR One was founded in 1985